Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The FMC Corporation (NYSE: FMC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a global agricultural sciences company focused on crop protection, biologicals, crop nutrition, and digital and precision agriculture, FMC uses its SEC reports to detail its financial condition, restructuring activities, capital structure and governance.
Investors can review current reports on Form 8-K, where FMC discloses material events such as quarterly earnings releases, leadership changes, restructuring initiatives and credit agreement amendments. For example, the company has filed 8-Ks describing quarterly financial results, the comprehensive Project Foundation cost optimization plan and Manufacturing Restructuring Program, and an amendment to its Fifth Amended and Restated Credit Agreement that adjusts leverage and interest coverage covenants and places conditions on dividends and indebtedness.
Through its periodic annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR and summarized on this page), FMC provides more detailed information on revenue by region, cost structure, research and development spending on new herbicide, insecticide and fungicide active ingredients, and risks related to competition, regulation and restructuring. These filings also describe the company’s geographic footprint, including its headquarters in Philadelphia, Pennsylvania, and its operations across North America, Latin America, Asia and EMEA.
The filings page also highlights governance and board-related disclosures, such as 8-K reports on director resignations or executive departures, and may include proxy materials that discuss executive compensation and board composition. For those monitoring capital structure and liquidity, filings related to credit facilities, covenant changes and potential asset sales—such as the planned divestiture of the India commercial business—are particularly relevant.
Stock Titan enhances these documents with AI-powered summaries that explain key points in plain language, helping users interpret complex sections of lengthy 10-Ks, 10-Qs and 8-Ks. Real-time updates from EDGAR ensure that new filings, including any Form 4 insider transaction reports or additional restructuring disclosures, appear promptly so investors can track how FMC’s financial and strategic decisions evolve over time.
Verduin Patricia reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Patricia Verduin received a grant of 9,175 shares of FMC common stock on April 28, 2026. The shares were awarded at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. Following this award, Verduin directly owns 16,326 FMC common shares.
FMC CORP director John Mitchell Raines received a grant of 9,175 shares of Common Stock on April 28, 2026. The shares were acquired as a grant or award at a stated price of $0.00 per share, increasing his direct holdings to 22,996 shares of FMC common stock.
FMC Corp director Robert C. Pallash reported a tax-related share disposition. On April 28, 2026, 18,843 shares of FMC common stock were used to satisfy a tax liability at an indicated value of $15.56 per share, classified as a tax-withholding disposition rather than an open-market sale. After this transaction, Pallash directly owned 41,827 shares of FMC common stock.
FMC Corp director Margareth Oevrum had 680 shares of Common Stock valued at $15.56 per share disposed of on April 28, 2026 as a tax-withholding disposition, meaning shares were delivered to cover tax obligations. After this routine transaction, she directly holds 21,813 shares of FMC stock.
FMC Corp director Steven T. Merkt received a grant of 9,175 shares of FMC common stock as a non-derivative award. The shares were acquired at a stated price of $0.00 per share, indicating a compensation-related grant rather than a market purchase. Following this transaction, Merkt directly holds a total of 15,053 FMC common shares.
FMC CORP director KLynne Johnson reported a compensation-related share grant. On April 28, 2026, Johnson acquired 9,175 shares of FMC common stock at a stated price of $0.00 per share, increasing direct ownership to 44,351 shares. This reflects an equity award, not an open-market purchase.
FMC CORP director C. Scott Greer reported a tax-related share disposition. On April 28, 2026, 1,032 shares of FMC common stock were withheld at $15.56 per share to cover tax obligations, a non-market transaction. Greer now directly holds 73,568 FMC shares.
FMC Corp director Kathy Lynn Fortmann received a stock award of 9,175 shares of Common Stock on April 28, 2026. The Form 4 classifies this as a grant or award acquisition at a reported price of $0.00 per share, indicating compensation rather than an open-market purchase. Following this grant, her directly held stake increased to 23,552 shares, providing context on the scale of her ownership relative to this single award.
DAVIDSON CAROL ANTHONY reported acquisition or exercise transactions in this Form 4 filing.
FMC CORP director Carol Anthony Davidson received a grant of 9,175 shares of Common Stock as compensation. The award was reported at a price of $0.00 per share, indicating it was a non-cash grant. Following this transaction, Davidson directly holds 32,491 FMC CORP common shares.
FMC Corp director Eduardo E. Cordeiro received a grant of 9,175 shares of common stock as equity compensation. The award was reported as an acquisition on a Form 4 with no purchase price per share, indicating it was granted rather than bought in the market.
Following this grant, Cordeiro directly holds 40,880 shares of FMC common stock. This filing reflects a compensation-related stock award, not an open-market transaction.